Biolase Inc (BIOL)
0.10
+0.02
(+31.63%)
USD |
OTCM |
Jun 28, 16:00
Biolase Revenue (Annual): 49.16M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 49.16M |
| December 31, 2022 | 48.46M |
| December 31, 2021 | 39.19M |
| December 31, 2020 | 22.78M |
| December 31, 2019 | 37.80M |
| December 31, 2018 | 46.16M |
| December 31, 2017 | 46.93M |
| December 31, 2016 | 51.81M |
| December 31, 2015 | 48.48M |
| December 31, 2014 | 47.66M |
| December 31, 2013 | 56.43M |
| December 31, 2012 | 57.36M |
| December 31, 2011 | 48.86M |
| December 31, 2010 | 26.22M |
| December 31, 2009 | 43.35M |
| December 31, 2008 | 64.62M |
| Date | Value |
|---|---|
| December 31, 2007 | 66.89M |
| December 31, 2006 | 69.70M |
| December 31, 2005 | 61.98M |
| December 31, 2004 | 60.65M |
| December 31, 2003 | 48.78M |
| December 31, 2002 | 27.26M |
| December 31, 2001 | 16.55M |
| December 31, 2000 | 9.657M |
| December 31, 1999 | 7.004M |
| December 31, 1998 | 1.50M |
| December 31, 1997 | 1.80M |
| December 31, 1996 | 0.70M |
| December 31, 1995 | 1.20M |
| December 31, 1994 | 1.10M |
| December 31, 1993 | 2.40M |
| December 31, 1992 | 5.50M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
22.78M
Minimum
2020
49.16M
Maximum
2023
39.48M
Average
39.19M
Median
2021
Revenue (Annual) Benchmarks
| Dentsply Sirona Inc | 3.965B |
| Milestone Scientific Inc | 9.827M |
| Wellness Center USA Inc | 0.24M |
| Envista Holdings Corp | 2.566B |
| Sonendo Inc | 43.86M |